Modernizing the good faith inquiry process

Kalderos Discount Hub is an easy-to-use tool that allows manufacturers to work with 340B covered entities in “good faith” to validate suspected duplicate discounts.

Respond to manufacturers quickly and efficiently

Kalderos collects data from multiple manufacturers and payers so you don’t have to, and houses everything you need to confirm suspected noncompliance within Discount Hub.

Ensure drug discount program compliance

Discount Hub serves as a single source of information to reduce the complexity and administrative burden of compliance, expediting the good faith inquiry process to support program integrity.

Discount Hub benefits
An industry-leading solution to support your covered entity
Collaboration with all stakeholders
Collaboration is crucial to ensure 340B compliance. Discount Hub allows teams to work together and with outside partners to provide responses to good faith inquiries.
Historical datasets at your fingertips
Support your compliance recordkeeping with documentation and details of all prior responses, which are easily accessible within your Discount Hub account.
A single touchpoint for your good faith inquiries
We leverage our industry-leading algorithm to identify claims for review, placing them all in a single platform.
A source of comprehensive data
Kalderos continuously analyzes and brings together data from your state Medicaid agency and pharmaceutical manufacturers.
Discount Hub features

The tools your team needs to complete good faith inquiries

About good faith inquiries

Good faith inquiries are an important part of ensuring 340B Program integrity. Are good faith inquiries the same as audits? No. Rather, they are "good faith" attempts to resolve concerns related to duplicate discounts. HRSA encourages these types of "good faith" collaborations. Here are some examples of HRSA guidance:

Per HRSA's proposed omnibus guidance: "A manufacturer should work in good faith with a covered entity to resolve any concerns related to duplicate discounts and diversion of 340B drugs before requesting HHS approval to audit the covered entity." 

Per the 1996 audit guidelines: "The manufacturer and the covered entity must make a good faith effort to resolve the issue ..."
What's next

Join us, and start  managing your good faith inquiries

Get in touch
Get started with Kalderos Discount Hub
By submitting this form, I agree that Kalderos may contact me at the email address above to tell me about its services. See our Privacy Policy for more details or to opt-out at any time.
Thank you! Your submission has been received.
We will get back to you shortly.
Oops! Something went wrong while submitting the form.
All your good faith inquiries, one convenient tool.
Collaboration with all stakeholders
A single touchpoint for your good faith inquiries
Historical datasets at your fingertips
A source of comprehensive data
Additional assistance

Get answers to all of your questions about Kalderos and Drug Discount Management.

Customer Support

Visit Kalderos’ help center for assistance with your Kalderos account.


Find out how we’re redefining how the business of healthcare performs.